+91-8668442535

Interventional Cardiology & Peripheral Vascular Devices Market By Product (Angioplasty Stents, Angioplasty Balloon Catheter, Guidewires, Vascular Closure Devices, Peripheral Embolic Protection Devices, Atherectomy Devices, Endovascular Stent Grafts, Vascular Grafts, Thrombectomy Devices, Inferior Vena Cava Filter) - Growth, Future Prospects & Competitive Analysis, 2017 – 2025

Cardiovascular diseases, one of the primary causes of global mortality, were responsible for 17.7 million deaths worldwide, as reported by the World Health Organization (WHO). This global burden of death raised the importance of taking preventive health measures and focusing on the development of improved treatment devices in order to achieve effective clinical outcomes. Interventional method deployment in cardiology and peripheral vascular disease treatment is mostly preferred to avoid complications and scarring, reduce pain, and promote faster recovery.

The purpose of the research report titled "Interventional Cardiology and Peripheral Vascular Devices Market: Growth, Future Prospects, and Competitive Analysis, 2017–2025" is to provide industry experts and business executives with an overall in-depth analysis to empower them in building business strategies and in the process of tactical decision making related to the prospects of the interventional cardiology and peripheral vascular devices market. The report effectively conveys a comprehensive investigation of market dynamics, which contains significant market-driving factors, limitations, opportunities, and challenges. This report additionally gives existing key patterns and the future extent of interventional cardiology and peripheral vascular devices in conjunction with information for the base year 2016 and forecasts from 2017 to 2025.

Because of the rising prevalence of cardiovascular diseases, the interventional cardiology and peripheral vascular devices market is expanding at a moderate CAGR. In the near future, the growing preference for minimally invasive procedures will propel the growth of the interventional cardiology and peripheral vascular devices markets. Cardiovascular diseases are more prevalent in the elderly population; thus, the rising geriatric population contributes to major growth in the interventional cardiology and peripheral vascular devices markets. An upsurge in high cholesterol, hypertension, and diabetes mellitus as a result of a sedentary lifestyle is expected to drive market growth.

The American Heart Association funded more than US$ 163.0 million for 980 cardiovascular disease research projects between 2015 and 2016; rising government spending on health has driven significant market growth. Escalating health awareness among the public with various healthcare initiatives in developing nations contributes to market growth. Evolving technological advancements for developing improved devices and favorable reimbursement policies are further projected to drive the growth of the interventional cardiology and peripheral vascular devices markets. Furthermore, the high cost of treatment procedures and the availability of traditional open surgical procedures may pose challenges to the market's smooth growth.

The global interventional cardiology and peripheral vascular devices market has been classified into different types of products deployed for the purpose of treating cardiovascular diseases, such as angioplasty stents, balloon catheters, guidewires, vascular closure devices, peripheral embolic protection devices, atherectomy devices, endovascular stent grafts, vascular grafts, thrombectomy devices, inferior vena cava filters, and other interventional devices. This report covers the cross-sectional data of each and every segment, considering 2016 as the base year, and predicts the market trend up to 2025 along with a CAGR of 2017–2025.

Based on the geographical regions, the global market for interventional cardiology and peripheral vascular devices has been classified into major regions and sub-regions as below:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • U.K.
    • Russia
    • Rest of Europe
  • Asia-Pacific
    • India
    • China
    • Japan
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East and Africa

This research report incorporates exhaustive profiling of a couple of prevailing players in the interventional cardiology and peripheral vascular devices market, along with complete financial details. The key industry players are Cook Medical, Inc., Boston Scientific Corporation, Cardinal Health, Inc., St. Jude Medical, Abbott Laboratories, C. R. Bard, Inc., Medtronic plc., Edwards Lifesciences Corporation, Terumo Corporation, B. Braun Melsungen AG, Baxter International Inc., 3M Company, and other noteworthy players.

Based on the various types of products utilized in interventional cardiology and to treat peripheral vascular disease, the global interventional cardiology and peripheral vascular devices market is categorized as follows:

  • Angioplasty Stents
  • Balloon Catheter for Angioplasty
  • Guidewires
  • Vascular Closure Devices
  • Peripheral Embolic Protection Devices
  • Atherectomy Devices
  • Endovascular Stent Grafts
  • Vascular Grafts
  • Thrombectomy Devices
  • Inferior Vena Cava Filter
  • Others (Hemodynamic Flow Alteration Devices, Plaque Modification Devices, Balloon Inflation Devices)

Coronary heart disease is the most common heart ailment, affecting millions of people across the globe. Interventional cardiac procedures are witnessing an increase in demand since angioplasty has revolutionized the treatment of coronary diseases by lowering post-surgery cardiac complications, reducing the risk of nosocomial infections, and promoting faster recovery. The preference for angioplasty stents is on the rise due to the rising prevalence of atherosclerosis, where mesh-like stents act as a support to keep blocked vessels open. However, the risk of restenosis would hamper the overall growth of the stent market and, subsequently, the interventional cardiology and peripheral vascular devices markets.

Angioplasty balloon catheters are experiencing lucrative growth as they ensure safety and efficient results, which is driving the market's growth. Fueled by technological advancements, vascular closure devices have successfully provided improved interventional procedures compared to manual closure techniques, thereby boosting the industry's growth. Thrombectomy devices, atherectomy devices, and embolic protection devices offer effective clinical outcomes and lower the chances of restenosis. The paradigm shift towards interventional approaches in order to treating cardiovascular diseases has propelled the global market. Furthermore, the traditional and conventional approach to treating cardiovascular disease and the high cost of treatment might pose challenges to the growth of the global interventional cardiology and peripheral vascular devices markets.

Geographically, the global interventional cardiology and peripheral vascular devices market are cumulative for North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America.

The global market for interventional cardiology and peripheral vascular devices is anticipated to be dominated by North America, followed by Europe. The Centers for Disease Control and Prevention (CDC) stated that every year, 610,000 deaths occur due to cardiovascular diseases in the United States. Cardiovascular diseases are considered the leading cause of death in North America due to a sedentary lifestyle and obesity. According to the British Heart Foundation, in the United Kingdom, 7 million people suffered from cardiovascular disease in 2015. Such a high prevalence of cardiovascular diseases drives the interventional cardiology and peripheral vascular devices market. However, the interventional cardiology and peripheral vascular devices market in North America is expected to face some challenges as a result of competitive pricing pressure and a decrease in the insured population following the country's financial downturn.

The statistics published by the American Heart Association revealed that in Asia-Pacific, 6.1% of the population had heart disease, 3.7% of the population was suffering from coronary heart disease, and 21% had hypertension in the year 2015. The market in Asia Pacific is expected to experience a sharp rise during the forecast period due to the growing prevalence of cardiovascular diseases, predominantly in Japan. Japan contributes the largest share of the total sales of interventional cardiology and peripheral vascular devices across Asia Pacific due to its high geriatric population, which is more susceptible to cardiac disease. The risk factors associated with cardiovascular disorders, such as the prevalence of high cholesterol, hypertension, and diabetes mellitus, are on the rise, which plays a major role in the market growth of interventional cardiology and peripheral vascular devices. As per the recorded data by the Institute for Health Metrics and Evaluation, a 97% increase in cardiovascular death was observed between 1990 and 2013. However, emerging healthcare awareness and developing economies and healthcare infrastructure support the growth opportunity of the interventional cardiology and peripheral vascular devices markets in the Asia Pacific region.

The global interventional cardiology and peripheral vascular devices market is presented as follows:

  • North America (the United States and Canada)
  • Europe (the United Kingdom, Germany, and the rest of the European countries)
  • Asia Pacific (India, Japan, China, and the rest of the Asia Pacific countries)
  • Latin America (Mexico, Brazil, and the rest of LATAM countries)
  • Middle East and Africa (GCC, South Africa, and the rest of the MEA) 

Frequently Asked Question:

The market for Interventional Cardiology & Peripheral Vascular Devices Market is expected to reach USD$ 14.53 Bn in 2025.

The Interventional Cardiology & Peripheral Vascular Devices Market is expected to see significant CAGR growth over the coming years, at 8.8%.

The report is forecasted from 2017 -2025.

The base year of this report is 2016.

Cook Medical, Inc., Boston Scientific Corporation, Cardinal Health, Inc., St. Jude Medical, Abbott Laboratories, C. R. Bard, Inc., Medtronic plc. are some of the major players in the global market.

Choose License Type
Trusted By
Godaddy
Published Date:  Dec 2017
Category:  Medical Devices
Report ID:   58895
Report Format:   PDF
Pages:   120
Rating:    4.8 (80)
Delivery Time: 24 Hours to 48 Hours   
Connect With Us
+91-8668442535
24/7 Research Support